eXoZymes, Inc.
EXOZ
$7.80
-$0.82-9.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.27M | 1.58M | 1.31M | 1.75M | 1.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.39M | 2.70M | 2.52M | 2.55M | 1.95M |
| Operating Income | -2.39M | -2.70M | -2.52M | -2.55M | -1.95M |
| Income Before Tax | -2.37M | -2.76M | -2.29M | -2.36M | -1.86M |
| Income Tax Expenses | -- | -105.20K | -- | -- | -- |
| Earnings from Continuing Operations | -2.37M | -2.66M | -2.29M | -2.36M | -1.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.37M | -2.66M | -2.29M | -2.36M | -1.86M |
| EBIT | -2.39M | -2.70M | -2.52M | -2.55M | -1.95M |
| EBITDA | -2.31M | -2.62M | -2.45M | -2.48M | -1.88M |
| EPS Basic | -0.28 | -0.32 | -0.27 | -0.28 | -0.22 |
| Normalized Basic EPS | -0.18 | -0.21 | -0.17 | -0.18 | -0.14 |
| EPS Diluted | -0.28 | -0.32 | -0.27 | -0.28 | -0.22 |
| Normalized Diluted EPS | -0.18 | -0.21 | -0.17 | -0.18 | -0.14 |
| Average Basic Shares Outstanding | 8.46M | 8.39M | 8.39M | 8.38M | 8.37M |
| Average Diluted Shares Outstanding | 8.46M | 8.39M | 8.39M | 8.38M | 8.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |